Tier 2 Dermatology Service for Mid and South Essex

This is a contract award notice and is intended to provide notice of NHS Mid and South Essex Integrated Care Board (herein "the Authority")'s intention to award a contract to deliver Tier 2 Dermatology Services to the patients within Mid and South Essex's geographical footprint. The contract will be for 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £809,230.

This contract award notice is made following the Authority's publication of the voluntary ex ante transparency notice (Notice Number: 2023/S 000-037586) on the 21st December 2023 which outlined the rationale and reasoning for the Authority's decision to award this contract, under Regulation 32 (2) (c) of the Public Contract Regulations 2015 ("PCR 2015") (as amended The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020).

In line with best practice, the Authority has observed the 10-day standstill period from the publication date of the voluntary ex-ante Notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.)

The Authority intends to award this provision to incumbent provider Mayflower Healthcare Alliance for a period of 12 months, from 01st April 2024 - 31st March 2025 . The aggregate contract value is forecasted at £809,230.

Additional information: The Service to which this procurement relates fall within Schedule 3 of the Public Contracts Regulations 2015 as amended by as amended by The Public Procurement (Amendment etc.) (EU Exit) Regulations 2020, (the "Regulations"). As such, the Authority does not intend to hold itself bound by any of the Regulations, save those applicable to Schedule 3 Services.

This Contract Award Notice is being published in both Find a Tender Service (FTS) and Contracts Finder following the publication of the Voluntary Ex Ante Notice (VEAT) (Notice Number 2023/S 000-037586) which was published on the 21st December 2023. The Authority has observed the 10 day standstill period and will award this contract.

This contract is to ensure continuity of care, safe and effective access to care and dermatology services for the patients of Mid and South Essex during this transitional, interim period. The Authority will publish appropriate Notices accordingly to communicate any such future changes to the market, once final.